Abstract
We review our current understanding of the molecular determinants and mechanisms of lymphocyte apoptosis and identify the key regulators of these death-signaling pathways. In addition, we describe the key molecular aberrations that underlie the resistance of lymphomas to conventional therapy, and highlight the enormous promise of potential therapeutic strategies that could circumvent or overcome these genetic impediments to apoptosis.
Original language | English (US) |
---|---|
Pages (from-to) | 490-503 |
Number of pages | 14 |
Journal | Current opinion in oncology |
Volume | 14 |
Issue number | 5 |
DOIs | |
State | Published - Sep 2002 |
ASJC Scopus subject areas
- Oncology
- Cancer Research